Cutaneous malignant melanoma: clinical aspects, imaging modalities and treatment
β Scribed by I. Ak; M.P.M. Stokkel; W. Bergman; E.K.J. Pauwels
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 421 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Diagnostic accuracy for melanoma was determined in a dedicated pigmented lesion clinic. We assessed the impact of duration of experience in dermatology and also the relationship between tumour thickness and accuracy of clinical diagnosis. We reviewed the histopathology request forms and reports for
The authors thank the staff of the Cancer Registry of Western Australia, the private and public pathology laboratories, the hospitals and clinicians in Western Australia for their assistance in supplying information.
W e are grateful for the results from Dr. RodrΔ± Β΄guez et al. supporting our previous article. 1 We agree with their conclusion that a combination assay of CYFRA 21-1 with carcinoembryonic antigen (CEA) and CA 15-3 is very useful for breast carcinoma, since the epitope of CYFRA 21-1 is a polypeptide
Background. Cutaneous malignant melanoma (CMM) is increasing in frequency. Surgery remains the primary and only curative treatment method. Our aim was to define prognostic factors and outcome predictors for patients with clinical stage I CMM of the head and neck. Methods. Surgical treatment and out